Clarius Group, LLC
- SEC CIK
- 0001664214
- Latest filing
- Jan 14, 2026
SYRS holding history
Syros Pharmaceuticals, Inc. in every 13F filed by Clarius Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SYRS overviewAll 13F holders of SYRSFull Q4 2025 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −18,620−100.0% | Sold out | Holders |
| Q4 2024 | 18,620 | $4.28K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 18,620 | $40.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 18,620 | $96.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 18,620 | $99.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 18,620 | $145.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 18,620 | $73.5K | <0.1% | +18,620 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −18,620−100.0% | Sold out | Holders |
| Q1 2023 | 18,620 | $49.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 18,620 | $67.0K | <0.1% | −727−3.8% | Reduced | Holders |
| Q3 2022 | 19,347 | $125.0K | <0.1% | 00.0% | UnchangedConverted for a 1-for-10 split | Holders |
| Q2 2022 | 193,483 | $186.0K | <0.1% | +193,483 | New | Holders |